HUTCHMED (HCM) News Today $14.79 -0.25 (-1.66%) As of 03:29 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HCM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period HUTCHMED Highlights HMPL-A251 Data Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsOctober 22 at 8:43 PM | finance.yahoo.comAllianz Asset Management GmbH Sells 80,000 Shares of HUTCHMED (China) Limited Sponsored ADR $HCMOctober 21 at 4:08 AM | marketbeat.comHUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board CommitteeOctober 14, 2025 | globenewswire.comHUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO CongressOctober 12, 2025 | globenewswire.comHUTCHMED (NASDAQ:HCM) Rating Increased to Buy at Wall Street ZenOctober 11, 2025 | marketbeat.comWeiss Ratings Reaffirms Hold (C) Rating for HUTCHMED (NASDAQ:HCM)October 9, 2025 | marketbeat.comHUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Given Average Recommendation of "Hold" by BrokeragesOctober 3, 2025 | marketbeat.comHUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2025October 1, 2025 | globenewswire.comHUTCHMED (NASDAQ:HCM) Shares Gap Down - Time to Sell?September 23, 2025 | marketbeat.comMorgan Stanley Downgrades HUTCHMED (HCM)September 23, 2025 | msn.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Zymeworks (ZYME), HUTCHMED (HCM) and Zai Lab (ZLAB)September 14, 2025 | theglobeandmail.comHUTCHMED (NASDAQ:HCM) Shares Gap Up - Here's WhySeptember 14, 2025 | marketbeat.comHUTCHMED (NASDAQ:HCM) Rating Lowered to Hold at Zacks ResearchSeptember 13, 2025 | marketbeat.comHutchmed rises 10.4%September 12, 2025 | msn.comSave the Date: HUTCHMED to Present R&D Updates on October 31, 2025September 11, 2025 | globenewswire.comHUTCHMED (NASDAQ:HCM) Cut to "Hold" at Wall Street ZenSeptember 9, 2025 | marketbeat.comHUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025September 4, 2025 | globenewswire.comHUTCHMED (NASDAQ:HCM) Upgraded at Wall Street ZenSeptember 1, 2025 | marketbeat.comHUTCHMED (China) Limited: HUTCHMED Announces Appointment of Acting Chief Executive OfficerAugust 25, 2025 | finanznachrichten.deHUTCHMED CEO takes leave of absence; CFO Johnny Cheng appointed acting CEOAugust 25, 2025 | msn.comHUTCHMED Announces Appointment of Acting Chief Executive OfficerAugust 24, 2025 | globenewswire.comHUTCHMED Completes Patient Enrollment of SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in ChinaAugust 19, 2025 | globenewswire.comHUTCHMED (NASDAQ:HCM) Rating Lowered to Hold at Wall Street ZenAugust 18, 2025 | marketbeat.comHUTCHMED (NASDAQ:HCM) Downgraded by Wall Street Zen to BuyAugust 10, 2025 | marketbeat.comHUTCHMED (NASDAQ:HCM) Shares Gap Down - Here's What HappenedAugust 9, 2025 | marketbeat.comHUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Shares Bought by XY Capital LtdAugust 9, 2025 | marketbeat.comHUTCHMED (China) First Half 2025 Earnings: EPS: US$0.53 (vs US$0.03 in 1H 2024)August 9, 2025 | finance.yahoo.comHUTCHMED (NASDAQ:HCM) Trading Down 9.7% - Time to Sell?August 8, 2025 | marketbeat.comHUTCHMED (China) Limited (HCM) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comHUTCHMED (NASDAQ:HCM) Shares Gap Up - Should You Buy?July 30, 2025 | marketbeat.comAllianz Asset Management GmbH Lowers Holdings in HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM)July 26, 2025 | marketbeat.comHUTCHMED (NASDAQ:HCM) Stock Rating Upgraded by Wall Street ZenJuly 26, 2025 | marketbeat.comHUTCHMED (NASDAQ:HCM) Price Target Raised to $28.00 at Bank of AmericaJuly 22, 2025 | marketbeat.comHUTCHMED (NASDAQ:HCM) Sees Unusually-High Trading Volume - What's Next?July 9, 2025 | marketbeat.comHUTCHMED to Announce 2025 Half-Year Financial ResultsJuly 3, 2025 | globenewswire.comHUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor TherapyJune 30, 2025 | globenewswire.comHUTCHMED (NASDAQ:HCM) Upgraded by Wall Street Zen to "Strong-Buy" RatingJune 27, 2025 | marketbeat.comHUTCHMED (China) Limited (HCM.L) - Yahoo FinanceJune 26, 2025 | nz.finance.yahoo.comHUTCHMED (China) Limited (HCM) - Yahoo FinanceJune 26, 2025 | au.finance.yahoo.comHow Much Upside is Left in HUTCHMED (HCM)? Wall Street Analysts Think 73.52% - NasdaqJune 25, 2025 | nasdaq.comPaycom Software: Automating Payroll And HCM Solutions; Initiate With 'Buy'June 22, 2025 | seekingalpha.comHUTCHMED (NASDAQ:HCM) Downgraded to "Buy" Rating by Wall Street ZenJune 14, 2025 | marketbeat.comHUTCHMED (NASDAQ:HCM) Shares Gap Up - Time to Buy?June 12, 2025 | marketbeat.comHutchmed introduces new share options and LTIP awardsJune 11, 2025 | uk.investing.comHUTCHMED Grants Share Options and LTIP Awards to Boost Talent RetentionJune 10, 2025 | tipranks.comChina accepts NDA for sintilimab and fruquintinib combo in kidney cancerJune 4, 2025 | msn.comInnovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Renal Cell CarcinomaJune 4, 2025 | prnewswire.comHUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell CarcinomaJune 4, 2025 | globenewswire.comHUTCHMED (NASDAQ:HCM) Shares Gap Up - Still a Buy?June 3, 2025 | marketbeat.comHUTCHMED’s SACHI Phase III Study Shows Promising Results for Lung Cancer TreatmentJune 1, 2025 | tipranks.com Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HCM Media Mentions By Week HCM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCM News Sentiment▼0.200.63▲Average Medical News Sentiment HCM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCM Articles This Week▼23▲HCM Articles Average Week Get the Latest News and Ratings for HCM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for HUTCHMED and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BBIO News MRNA News RVMD News VRNA News RYTM News ABVX News MRUS News CYTK News RNA News NUVL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HCM) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredIt’s Time to Buy “the NVIDIA of Quantum Computing”Yahoo Finance wrote that investing in quantum computing could... "Lead to life-changing returns... and make...Brownstone Research | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredWhat Wall Street Won’t Say Out LoudDiscover the 7 key indicators before everyone else doesAmerican Alternative | SponsoredFree: The Crypto Summit That Could Change Your LifeFed cuts unleash crypto's next wave The smart money is already moving. This is your chance to see their car...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share HUTCHMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
